Misha Blagosklonny

Share on Social Media
Mikhail (Misha) Blagosklonny
Photo Courtesy of @blagosklonny

Dr. Mikhail (Misha) Blagosklonny Of Oncotarget

Dr. Mikhail (Misha) Blagosklonny is one of the Editor-in-Chiefs at Oncotarget, a weekly peer-reviewed open access scientific journal focusing on all topics surrounding cancer research. The Editorial Board at Oncotarget includes the most prominent cancer researchers in the world. In fact, Misha Blagosklonny is proud to say that during a short history of Oncotarget many Editorial Board members have become members of the National Academy of Sciences USA, won Lasker, Nobel and other prestigious awards.

The story of Mikhail (Misha) V. Blagosklonny started when he graduated with an MD and PhD from First Pavlov State Medical University of St. Petersburg, Russia. Dr. Misha Blagosklonny then moved to the United States where he became famous for contributions to  the research of cancer and aging.

Everything Dr. Misha Blagosklonny contributes to is to further understand the cause of cancer and find an efficient treatment. Soon,  Misha Blagosklonny and Oncotarget will once again be a major part of the Ride for Roswell. The Ride for Roswell is a community event in Buffalo, New York where funds are raised for the Roswell Park Comprehensive Cancer Center, the biggest cancer center in Upstate New York.  Mikhail Blagosklonny is proud to say that Oncotarget has been sponsoring a team of the event since 2018.

This website will serve as a place for Mikhail Blagosklonny of Oncotarget to inform the public on the latest news and information in cancer research.

MORE:

Visit Oncotarget.org for the latest articles about new and trending peer-reviewed scientific papers published by Oncotarget – a rigorously reviewed, weekly open access scientific journal focusing on all topics surrounding cancer research, and part of the Impact Journals family of scientific publications. Visit Oncotarget.net to learn about our community-based news and events.

CONTACT INFORMATION:

Dr. Blagosklonny can be followed on Twitter @Blagosklonny and you can learn more about him here

To get in touch with Oncotarget, please visit our website. The journal’s ISSN is 1949-2553 and is indexed and/or archived in PubMed, Scopus, PMC, and the Chan Zuckerberg Meta initiative.

Follow us on Twitter @Oncotarget!

Comments are closed.